期刊文献+

利培酮和氟哌啶醇对无血清诱导PC12细胞凋亡的作用 被引量:1

Effects of risperidone and haloperidol on PC12 cells from apoptosis induced by serum-free culture
原文传递
导出
摘要 目的探讨利培酮对神经的保护作用。方法以100 mg/L神经生长因子诱导大鼠PC12细胞7 d后,将细胞随机分为无血清组、氟哌啶醇组、利培酮组(氟哌啶醇组和利培酮组的浓度均分为10,20,40,60,80μmol/L)和血清组,每组5孔。采用四甲基偶氮唑盐(MTT)法测定细胞活性,流式细胞仪检测细胞凋亡率、细胞周期,用Hoechst33342染色法观察细胞形态学变化。结果(1)给予利培酮(20,40μmol/L)72 h后,细胞活性[(64.2±4.4)%,(60.8±3.9)%]高于无血清组[(48.0±2.8)%;P<0.01],而10μmol/L、20μmol/L、40μmol/L、60μmol/L、80μmol/L各浓度氟哌啶醇组的细胞活性[分别为(31.8±3.9)、和(24.4±1.3)%、(14.3±2.6)%、(10.5±2.1)%和(4.1±1.4)%]均低于无血清组(P<0.01)。(2)流式细胞仪检测,利培酮组的凋亡率[(34.6±2.8)%]低于无血清组[(50.7±3.1)%;LSDt-=-16.0,P<0.01],而氟哌啶醇组的凋亡率[(59.3±5.2)%]高于无血清组(LSD-t=8.6,P<0.01);血清组和利培酮组细胞滞留于G1期的比例[分别为(53.5±5.4)%和(71.1±3.7)%]低于无血清组[(81.2±3.0)%]和氟哌啶醇组[(82.1±5.7)%;P<0.01]。(3)无血清组和氟哌啶醇组多见凋亡细胞,其中氟哌啶醇组更明显;而利培酮组偶见凋亡细胞,以核浓缩为主。结论利培酮对PC12细胞有抗凋亡作用,可能是其参与神经保护作用的机制之一。 Objective To investigate the protective effect of risperidone on neuronal cells. Methods PC12 cells differentiation were performed by adding nerve growth factor at the concentration of 100 mg/L for 7 days in vitro, then the cells were randomly divided into four groups: serum-cultured, serumfree, haloperidol and risperidone treatment group. MTT assay was performed to determine cell viability. The apoptotic cell ratio and cell cycle were detected with flow cytometer assay. And the apoptotic morphological changes of PC12 cells were examined with Hoechst33342 staining. The effect of risperidone or halopefidol treatment was compared with that in serum-free group without treatment, respectively. Results ( 1 ) Cell viability in risperidone group at the concentration of 20 [ ( 64.2 ± 4.4) %] or 40 μmoVL [ ( 60.8 ± 3.9) % ] was significantly higher than that in serum-free group [ (48.0 ± 2.8 ) % ] after 72 h in vitro ( P 〈 0.01). However, Cell viability in haloperidol group at the concentration of 10 [ (31.8 ± 3.9)% 1, 20 [(24.4±1.3)%],40 [(14.3±2.6)%], 60 [(10.5 ±2.1)%], or 80 μmol/L [(4.1 ±1.4)%], was significantly lower than that in serum-free group (P 〈0.01 ). (2) Apoptotic ratios in risperidone group (34.6±2. 8) % was significantly lower than that in serum-free group [ (50.7 ± 3.1 ) % ; LSD-t = - 16.0, P 〈0.01 ] with flow cytometer assay, however, apoptotic ratios in haloperidol group (59.3 ± 5.2)% was significantly higher than that in serum-free group [ (50.7±3.1 ) % ; LSD-t = 8.6, P 〈 0.01 ]. The proportionof cells detained at G1 stage of cell circle in serum-cultured and risperidone groups [ (53.5 ± 3.4) % anct (71.1 ± 3.7)%, respectively], were lower than that in serum-free and haloperidol groups [ (81.2 ± 3.0) % and ( 82.1 ± 5.7 ) %, respectively ; P 〈 0.01 ]. ( 3 ) More apoptotic cells were observed in serumfree and haloperidol treatment groups, more in the latter, however, few in risperidone treatment group, most of which were characterized by karyopyknosis. Condusion Risperidone might have neuroprotective effect on neurons through rescuing cells from apoptosis.
出处 《中华精神科杂志》 CAS CSCD 北大核心 2006年第2期106-109,共4页 Chinese Journal of Psychiatry
基金 杨森科学基金资助项目(JRC2004)
关键词 PC12细胞 细胞死亡 神经保护药 利培酮 PC12 cells : Cell death Neuroprotective agents Risperidone
作者简介 研究生 通信作者:谭庆荣,Email:tanqingr@fmmu.edu.cn
  • 相关文献

参考文献12

  • 1Wyatt RJ, Henter ID. The effects of early and sustained intervention on the long-term morbidity of schizophrenia.J Psychiatr Res, 1998,32 : 169-177.
  • 2Lawrie SM, Abukmeil SS. Brain abnormality in schizophrenia: a systematic and quantitative review of volumetric magnetic resonance imaging studies, Br J Psychiatry, 1998, 172:110-120.
  • 3Gur RE, Cowell P, Turctsky BI, et al. A follow up magnetic resonance imaging study of schizophrenia. Relationship of neuroanatomical changes to clinical and neurobehavioral measures.Arch Gen Psychiatry, 1998, 55 : 145-152.
  • 4Young KA, Manaye KF, Liang C, et al. Reduced number of mediodorsal and anterior thalamic neurons in schizophrenia. Biol Psychiatry, 2000, 47:944-953.
  • 5Vinores SA, Marangos PJ, Parma AM, et al. Increased levels of neuron-specific enolase in PC12 pheochromocytoma cells as a result of nerve growth factor treatment.J Neurochem, 1981,37:597-600.
  • 6Hatanaka H. Nerve growth factor-mediated stimulation of tyrosine hydroxylase activity in a clonal rat pheochromocytoma cell line. Brain Res, 1981, 222:225-253.
  • 7Jarskog LF, Gilmore JH, Selinger ES, et al. Cortical bcl-2 protein expression and apoptotic regulation in schizophrenia.Biol Psychiatry, 2000, 48:641-650.
  • 8Jones EG. Cortical development and thalamic pathology in schizophrenia- Schizophr Bull, 1997, 23:483-501.
  • 9Batistatou A, Greene LA. Aurintricarboxylic acid rescues PC12 cells and sympathetic neurons from cell death caused by nerve growth factor deprivation: correlation with suppression of endonuclease activity. J Cell Biol, 1991, 115:461-471.
  • 10Perkins D, Yu Y, Bambrick LL, et al. Expression of herpes simplex virus type 2 protein ICP10 PK rescues neurons from apoptosis due to serum deprivation or genetic defects. Exp Neurol, 2002, 174:118-122.

同被引文献11

  • 1宋炜熙,王哲,黄川原,胡随瑜.抑郁模型大鼠蓝斑酪氨酸羟化酶表达研究[J].中国行为医学科学,2006,15(3):226-228. 被引量:7
  • 2Malberg JE.Implications of adult hippocampal neurogenesis in antidepressant action[J].J Psychiatry Neurosci,2004,29(3):196-205.
  • 3Hatanaka H.Nerve growth factor-mediated stimulation of tyrosine hydroxylase activity in a clonal rat pheochromocytoma cell line[J].Brain Res,1981,222(2):225-233.
  • 4Patris M,Bouchard JM,Bougerol T,et al.Citalopram versus fluoxetine:a double-blind,controlled,multicentre,phase III trial in patients with unipolar major depression treated in general practice[J].Int Clin Psychopharmacol,1996,11(2):129-136.
  • 5Thase ME,Feighner JP,Lydiard RB.Citalopram treatment of fluoxetine nonresponders[J].J Clin Psychiatry,2001,62(9):683-687.
  • 6Calabrese JR,Londborg PD,Shelton MD,et al.Citalopram treatment of fluoxetine-intolerant depressed patients[J].J Clin Psychiatry,2003,64(5):562-567.
  • 7Charlier C,Pinto E,Ansseau M,et al.Relationship between clinical effects,serum drug concentration,and concurrent drug interactions in depressed patients treated with citalopram,fluoxetin,clomipramine,paroxetine or venlafaxine[J].Hum Psychopharmacol,2000,15(6):453-459.
  • 8Kraemer GW,McKinney WT.Interactions of pharmacological agents which alter biogenic amine metabolism and depression-an analysis of contributing factors within a primate model of depression[J].J Affect Disord,1979,1(1):33-54.
  • 9Impey S,Obrietan K,Storm DR.Making new connections:role of ERK/MAP kinase signaling in neuronal plasticity[J].Neuron,1999,23(1):11-14.
  • 10Chang L,Karin M.Mammalian MAP kinase signalling cascades[J].Nature,2001,410(6824):37-40.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部